Mealey's PI/Product Liability - Directed Verdict, JMOL Denied In 1st Actos MDL Trial After Testimony Ends

Mealey's PI/Product Liability - Directed Verdict, JMOL Denied In 1st Actos MDL Trial After Testimony Ends

LAFAYETTE, La. - A Louisiana federal judge on April 2 denied the plaintiff's motion for a directed verdict and the defendant's motion for judgment as a matter of law (JMOL) in the first Actos bladder cancer multidistrict litigation trial (In Re: Actos $(Pioglitazone$) Products Liability Litigation, MDL Docket No. 2299, No. 6:11-md-2299, Allen v. Takeda Pharmaceuticals North America Inc., et al., No. 12-64, E.D. La.).

Access this news story on lexis.com®